Subtype and pathway specific responses to anticancer compounds in breast cancerLaura M. Heiser, Paul T. Spellman, Anguraj Sadanandam et al.|Proceedings of the National Academy of Sciences|2011Cited by 505
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinomaCindy Neuzillet, Hemant M. Kocher, Annemilaï Tijeras‐Raballand et al.|The Journal of Pathology|2018Cited by 284
SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancerHuafu Li, Axel Behrens, Mark Allen et al.|Nature|2025Cited by 20
Abstract 1979: Algebraic factorization of gene expression profiles reveals subtype-specific drug sensitivities among 54 breast cancer cell linesWilliam J. Gibb, Joe W. Gray, Eric A. Collisson et al.|Cancer Research|2010Cited by 0
Heterogeneity of human pancreatic adenocarcinoma (PDAC) cancer-associated fibroblasts (CAF): subtype-A (periostin-positive) CAF is associated with aggressive tumor features and is an early CAFCindy Neuzillet, Corinne Bousquet, Rémy Nicolle et al.|Pancreatology|2019Cited by 0